Chinese court freezes $318 million in Nexperia assets as Wingtech presses to regain control — Dutch chipmaker says seizures won't affect day-to-day operations
Promising new epilepsy drug delivers 80% reduction in seizures | Adults with drug-resistant focal onset seizures are the target of experimental epilepsy drug RAP-219
A 3D-printable hair-like electrode for brain monitoring
